Volume | 4,913 |
|
|||||
News | - | ||||||
Day High | 24.54 | Low High |
|||||
Day Low | 24.18 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
Fidelity Disruptive Medicine ETF | FMED | NASDAQ | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
24.52 | 24.18 | 24.54 | 24.228 | 24.4775 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
69 | 4,913 | 24.36 | 119,671 | - | 19.82 - 25.73 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 100 | 24.228 | USD |
Fidelity Disruptive Medicine ETF Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
51.46M | - | - | - | 34.29 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Fidelity Disruptive Medi...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
FMED Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 24.55 | 24.92 | 24.18 | 24.55 | 7,175 | -0.322 | -1.31% |
1 Month | 24.67 | 24.92 | 23.39 | 24.13 | 6,346 | -0.442 | -1.79% |
3 Months | 25.02 | 25.68 | 23.39 | 24.68 | 5,404 | -0.792 | -3.17% |
6 Months | 20.22 | 25.68 | 19.9587 | 23.72 | 6,461 | 4.01 | 19.82% |
1 Year | 25.12 | 25.73 | 19.82 | 23.49 | 7,683 | -0.892 | -3.55% |
3 Years | 25.12 | 25.73 | 19.82 | 23.49 | 7,683 | -0.892 | -3.55% |
5 Years | 25.12 | 25.73 | 19.82 | 23.49 | 7,683 | -0.892 | -3.55% |
The investment seeks high total return through a combination of current income and capital appreciation. The fund normally invests at least 80% of the fund's assets in preferred securities and other income-producing securities. It normally invests in all types of preferred securities and other income-producing securities such as contingent convertible securities and corporate hybrid securities. The fund primarily invests in securities rated at least BB by S&P, Ba by Moodys, comparably rated by at least one nationally recognized credit rating agency, or, if unrated, considered by FMR to be of comparable quality. It is non-diversified. |